Ian F Harrison
Title
Cited by
Cited by
Year
Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
IF Harrison, DT Dexter
Pharmacology & therapeutics 140 (1), 34-52, 2013
1912013
Application of neurite orientation dispersion and density imaging (NODDI) to a tau pathology model of Alzheimer's disease
N Colgan, B Siow, JM O'Callaghan, IF Harrison, JA Wells, HE Holmes, ...
Neuroimage 125, 739-744, 2016
1332016
The Discovery of a Highly Selective 5,6,7,8‐Tetrahydrobenzo[4,5]thieno[2,3‐d]pyrimidin‐4(3H)‐one SIRT2 Inhibitor that is Neuroprotective in an in vitro Parkinson …
P Di Fruscia, E Zacharioudakis, C Liu, S Moniot, S Laohasinnarong, ...
ChemMedChem 10 (1), 69-82, 2015
582015
Pathological histone acetylation in Parkinson’s disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition
IF Harrison, AD Smith, DT Dexter
Neuroscience letters 666, 48-57, 2018
572018
Non-invasive imaging of CSF-mediated brain clearance pathways via assessment of perivascular fluid movement with diffusion tensor MRI
IF Harrison, B Siow, AB Akilo, PG Evans, O Ismail, Y Ohene, P Nahavandi, ...
Elife 7, e34028, 2018
562018
An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson’s disease
IS Pienaar, IF Harrison, JL Elson, A Bury, P Woll, AK Simon, DT Dexter
Brain Structure and Function 220 (1), 479-500, 2015
512015
Prazosin, an α1-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease
L Katsouri, MP Vizcaychipi, S McArthur, I Harrison, M Suárez-Calvet, ...
Neurobiology of aging 34 (4), 1105-1115, 2013
462013
Neurorestoration induced by the HDAC inhibitor sodium valproate in the lactacystin model of P arkinson's is associated with histone acetylation and up‐regulation of …
IF Harrison, WR Crum, AC Vernon, DT Dexter
British journal of pharmacology 172 (16), 4200-4215, 2015
392015
Tissue magnetic susceptibility mapping as a marker of tau pathology in Alzheimer's disease
J O'callaghan, H Holmes, N Powell, JA Wells, O Ismail, IF Harrison, ...
Neuroimage 159, 334-345, 2017
382017
Non-invasive MRI of brain clearance pathways using multiple echo time arterial spin labelling: an aquaporin-4 study
Y Ohene, IF Harrison, P Nahavandi, O Ismail, EV Bird, OP Ottersen, ...
Neuroimage 188, 515-523, 2019
352019
Imaging the accumulation and suppression of tau pathology using multiparametric MRI
HE Holmes, N Colgan, O Ismail, D Ma, NM Powell, JM O'Callaghan, ...
Neurobiology of aging 39, 184-194, 2016
352016
Comparison of in vivo and ex vivo MRI for the detection of structural abnormalities in a mouse model of tauopathy
HE Holmes, NM Powell, D Ma, O Ismail, IF Harrison, JA Wells, N Colgan, ...
Frontiers in neuroinformatics 11, 20, 2017
292017
Impaired brain glymphatic flow in experimental hepatic encephalopathy
A Hadjihambi, IF Harrison, M Costas-Rodríguez, F Vanhaecke, N Arias, ...
Journal of hepatology 70 (1), 40-49, 2019
272019
Impaired glymphatic function and clearance of tau in an Alzheimer’s disease model
IF Harrison, O Ismail, A Machhada, N Colgan, Y Ohene, P Nahavandi, ...
Brain 143 (8), 2576-2593, 2020
262020
The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson's disease
IF Harrison, NM Powell, DT Dexter
Journal of neurochemistry 148 (1), 136-156, 2019
232019
Non-Invasive MRI of Blood–Cerebrospinal Fluid Barrier Function
PG Evans, M Sokolska, A Alves, IF Harrison, Y Ohene, P Nahavandi, ...
Nature communications 11 (1), 1-11, 2020
172020
Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate
IF Harrison, HK Anis, DT Dexter
Neuroscience letters 614, 16-23, 2016
152016
Study the longitudinal in vivo and cross-sectional ex vivo brain volume difference for disease progression and treatment effect on mouse model of tauopathy using automated MRI …
D Ma, HE Holmes, MJ Cardoso, M Modat, IF Harrison, NM Powell, ...
Frontiers in neuroscience 13, 11, 2019
142019
Optic nerve thinning and neurosensory retinal degeneration in the rTg4510 mouse model of frontotemporal dementia
IF Harrison, R Whitaker, PM Bertelli, JM O’Callaghan, L Csincsik, ...
Acta neuropathologica communications 7 (1), 1-14, 2019
82019
Imaging of x-ray-excited emissions from quantum dots and biological tissue in whole mouse
SG Ryan, MN Butler, SS Adeyemi, T Kalber, PS Patrick, MZ Thin, ...
Scientific reports 9 (1), 1-10, 2019
72019
The system can't perform the operation now. Try again later.
Articles 1–20